NAME: Mr Porter ADMISSION STATUS: Naso Pharyngeal Carcinoma
GENDER: Male NGPDT TREATMENTS: 3 Treatment Courses
AGE: 62 RELEASE STATUS: Positive / Necrosis
ONGOING STATUS: Pathology Report confirms non-cancerous Lymph node, patient alive and well.

In early 2011 Mr Porter noticed two lumps that had grown in size within a two month period. He then was diagnosed with Naso Pharyngeal Carcinoma with extension to the Lymph node of the neck. His local doctors in the United States of America recommended a variety of treatments such as an operation, Chemotherapy and Radiation.
After looking at his treatment options, the patient immediately travelled to Guangzhou China to receive 3 full course treatments of NGPDT. Patient started his first treatment in late April 2011 which was one month after an approxiamate 3 months tumour growth time.

Before treatment the tumor was difficult to see in the upper rear section of the mouth but after a first light treatment the cancer could easily be seen due to change of appearance and color to a "milky white". NGPDT Photosoft Agent was proven to be highly selective, and only accumulated in tumor sites leaving healthy tissue unaffected.

Ultra Sound was conducted before and after first 8 day treatment course, images were taken to show any progress/deterioration of tumor site of the neck. The ultrasound revealed the lymph node of the neck had changed from a solid hard state to a liquid mass. Patient experienced inflammation to the lymph node of the neck showing a successful immune response. The cancerous area of the mouth showed new fresh skin cell growth in place of the tumor site.

After 3 full course treatments the patient's neck was swollen, patient was concerned so biopsy was conducted on patients arrival back to the U.S. Pathology report showed inflammatory cell response and macrophages (the cells that rid the body of debris from fragmented cells). No cancer cells were detected in the pathology report. Biopsy taken was a fluid sample of approx. two(2) cc's of fluid taken from the left lymph node which was previously swollen with cancerous tumour.

Cancerous Lymph Node Cure
Biopsy and Pathology report after NGPDT treatment of the Lymph node
Cancer Post Treatment CT Scan
Scan CT image taken on 13/01/2012 (10 months comparison 29/03/2011)
Pathology report give Benign or non cancerous lymph node prognosis, however the doctor reveiwing the report made a statement "still concerned about the possibility of persistent cancer. I recommend we try radiation". This is a typical reaction of doctors that don't understand PDT even though the pathology showed no cancer cells. General Medical practitioners are often out of touch with breaking medical procedures as clearly shown by this practitioners statements.

Patient has successfully avoided radiation or chemo therapy due the success of his NGPDT treatment. A future CT/PET scan will be completed at a much later date to confirm no cancerous metastasis. The reason for the long interval recommended is due to CT/PET scans not being able to distinguish the difference between general inflammation and tumor tissue... Hence a perod of time is required for the body to repair and inflammatory response to complete.

NAME: Mr Kong ADMISSION STATUS: Stage 3 Anaplastic Astrocytoma
GENDER: Male NGPDT TREATMENTS: 2 Treatment Courses
AGE: 43 RELEASE STATUS: Positive / Necrosis
ONGOING STATUS: Alive and well 18 months after treatment.

The patient received tumor ablation on the left pulmonary lobe, however the tumour could not be thoroughly ablated during the operation, pathology report following the operation was diagnosis of Anaplastic Astrocytoma. Post operative CT Scan showed recurrence at the original tumor site. The patient was admitted to our NGPDT Treatment Centre and given his first 9 day treatment course. Patient reported no discomfort during the treatment, absence of previously experienced head-aches, improved memory after one treatment course. Post treatment CT Scan 5 months later showed that the recurrent tumor in the original operation site had disappeared completely. Patient reported he felt totally recovered, and the life had returned to normal. Patient received a second NGPDT treatment course for follow-up. Patient is working and living a normal life.

This patient is now within our follow-up monitoring program. The doctor who took charge of his operation stated prior to NGPDT that the future situation of this patient would degrade, and gave a median survival time would have been 3 months. Since treatment this patient has been living for more than half a year with his health improving daily. Patient is still working and feeling well.

NAME: Mr Mo ADMISSION STATUS: Metastatic Lung Cancer
GENDER: Male NGPDT TREATMENTS: 3 Treatment Courses
AGE: 70 RELEASE STATUS: Positive / Necrosis
ONGOING STATUS: Alive and well 12 months after treatment. Original diagnosis was less than 3 months to live.

The patient’s condition was very poor on admission to our treatment centre. Felt constant pain in his chest and experienced breathing difficulties with frequent coughing. NGPDT Check-up prior to treatment with the following diagnosis...

• Trachea had a deviation to the right.
• Percussion on left lung indicated lung had collapsed.
• Severe wheeze in right lung.
• Heart rate of 108 beats/minute.
• Abdomen examination showed no abnormalities.
• Chest X-ray showed left lung atelectasis, large amount of pleural effusion, 3000mls of pleural effusion with blood was drawn out after chest puncture.
• Metastatic Carcinoma on right lung.

First course of Next Generation PDT was begun immediately. Simultaneous “Shenqi Fuzheng Zhusheye” (Pilose Asiabell Root & Astragalus Root Injection) and nutrition support therapy was also administered. Post treatment checkup after two sessions of PDT light therapy found the general condition of the patient had improved, breathing difficulty had been noticeably alleviated, pleural effusion had been reduced to slight encapsulated fluid.
On the third day of NGPDT light treatment dead cancer cells were found in the pleural effusion. Patient reported chest pain had been noticeably abated. During the treatment this patient still smoked 20-30 cigarettes daily and drank alcohol. After 3 courses of NGPDT patients quality of life had noticeably improved. Examination performed on the day the patient was release from hospital was generally positive and a slight retraction of the tumour could already be noticed on his chest.

A visit to the patient in May found the patient was living a normal life. His daily cigarette consumption was still 30/day, and alcohol consumption was still excessive, however chest pain had disappeared, and the patient reported he no longer needed to take pain medication. 18 months have passed since NGPDT treatment and the patient is still alive and well. Doctors had given this patient less than 3 months to live when originally diagnosed.

NAME: Mr Zhang ADMISSION STATUS: Brain Astrocytoma
GENDER: Male NGPDT TREATMENTS: 1 Treatment Course
AGE: 44 RELEASE STATUS: Positive / Improved Health
ONGOING STATUS: Patient is taking part in our follow-up monitoring program.

This patient received an operation for diagnosed Brain Astrocytoma prior to him approaching NGPDT for treatment. The tumor could not be thoroughly ablated during the operation. The patient had headache, dizzyness, homonymous hemianopia in both eyes, and short term memory had been significantly weakened along with other minor symptoms. NGPDT checkup was carried out prior to beginning treatment with the following findings....

• Patient was clear-headed, could answer questions well.
• Aniscoria was evident, however both pupils were round and showed appropriate sensitivity to light.
• Eyeball movement seemed fine.
• Homonymous Hemianopia on the side of both eyes.
• Nystagmus (-) Audition was normal, strength of extremity muscle was normal, no nausea disorder.
• Both sides Babinski’s sign (-) patellar reflex was normal, no Hoffmann’s sign (-).
• No abnormality of heart, lungs or abdomen were found.

This patient was administered one round of treatment of Next Generation PDT after admission to our treatment centre. After the second session of light therapy, patient stated his headache and dizziness were no longer prevalent. Previously experienced dim eyesight and blurred vision had improved significantly. Patients sleep had also improved significantly. This patient is within our follow-up monitoring program and is currently alive and well.

NAME: Mr Li ADMISSION STATUS: Neurinoma of the Peritoneum
GENDER: Male NGPDT TREATMENTS: 3 Treatment Courses
AGE: 60 RELEASE STATUS: Positive / Improved Health
ONGOING STATUS: Patient is taking part in our follow-up monitoring program.

Patient had had two operations for Tumour of the Peritoneum prior to assessment by NGPDT Specialists. The patient approached NGPDT to request treatment for lumps that had re-appeared in the abdomen. Pre-treatment assessment was carried out with the following diagnosis....

• Palpable 17cm x 17cm lump on the Right Hypogastrium with clear border, elasticity was hard and tender.
• Palpable 5cm x 5cm lump beneath the Pocessus Xiphoideus connected to enclosed mass in the Right Hypogastrium.
• Bowel sound was active, no gurgling. Abdomen circumference was 79cm. No Inguen lymph node enlargement.

Three periods of NGPDT treatment were prescribed on admission to our treatment centre. Vein infusion of “Shenqi Fuzheng Zhusheye” was administered during the treatment to assist in the removal of necrotic material and other toxic products. General status of the patient was positive throughout the NGPDT treatment course, his appetite and sleep were normal with the patient experiencing very little, if any fatigue as a result of the treatment. The Abdomen tumour enlarged during the first treatment indicating the body's natural defenses had recognized the tumour and were attacking it. No further changes were observed during the second and third treatments other than a softening of the tumour tissue. Patient is still healthy, active, and being monitored in our follow-up program.

NOTE: Please be sure to check our video archives for other patient stories while we update this section of the NGPDT website. CLICK HERE TO VIEW